HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Excess of activating killer cell immunoglobulin‑like receptors and lack of HLA-Bw4 ligands: a two‑edged weapon in chronic fatigue syndrome.

Abstract
Chronic fatigue syndrome (CFS) is an inflammatory disease of unknown aetiology. Researchers have proposed infectious, neurological and immunological causes of this syndrome. Recently, the xenotropic murine leukemia virus-related virus was detected in 67% of patients with CFS in a US study. This observation is in agreement with one ascertained aspect of the disease: a decreased efficiency in NK cell lytic activity in CFS patients. Here, we analyzed the genomic polymorphism of killer cell immunoglobulin-like receptors (KIRs) and their HLA class I cognate ligands in patients with certified CFS. An excess of KIR3DS1 was found in CFS patients with respect to controls, as well as an increased frequency of the genotype missing KIR2DS5. Forty-four CFS patients and 50 controls also underwent genomic typing for the HLA-ligands. In the patients, a great proportion of KIR3DL1 and KIR3DS1 receptors were found to be missing their HLA-Bw4Ile80 binding motif. We hypothesize that an excess of KIR3DS1, combined with an excess of ligand-free KIR3DL1 and KIR3DS1 receptors, may hamper the clearance of a pathogen via NK cells, thus favouring the chronicity of the infection.
AuthorsAnnamaria Pasi, Sara Bozzini, Nicoletta Carlo-Stella, Miryam Martinetti, Stefano Bombardieri, Annalisa De Silvestri, Laura Salvaneschi, Mariaclara Cuccia
JournalMolecular medicine reports (Mol Med Rep) 2011 May-Jun Vol. 4 Issue 3 Pg. 535-40 ISSN: 1791-3004 [Electronic] Greece
PMID21468604 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-B Antigens
  • HLA-Bw4 antigen
  • Ligands
  • Receptors, KIR
Topics
  • Case-Control Studies
  • Fatigue Syndrome, Chronic (genetics, immunology)
  • HLA-B Antigens (immunology)
  • Heterozygote
  • Humans
  • Italy
  • Ligands
  • Linkage Disequilibrium (genetics)
  • Receptors, KIR (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: